HAVCR2 and systemic inflammatory response syndrome: We have previously shown that the compromised innate and adaptive anti-bacterial immunity in SAH could be maneuvered to a more favorable state through ex vivo neutralization of membrane-bound checkpoint receptors TIM3 and PD1 on lymphocytes, without inducing the production of cytokines associated with systemic inflammatory response syndrome (Markwick et al., 2015).